EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolomics Analysis Identifies Differential Metabolites as Biomarkers for Acute Myocardial Infarction

Jie Zhou, Hai-Tao Hou, Yu Song, Xiao-Lin Zhou, Huan-Xin Chen, Li-Li Zhang, Hong-Mei Xue, Qin Yang, Guo-Wei He iD

Biomolecules · 29.04.2024 · 14 (5) · 532

DOI: 10.3390/biom14050532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 29.04.2024. Verfasst von Jie Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular Hospital, Tianjin University, Tianjin 300…. Hauptthemen laut MEDLINE: Biomarkers, Metabolomics, Myocardial Infarction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Tianjin Municipal Science and Technology Commission, Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial infarction (MI), including ST-segment elevation MI (STEMI) and non-ST-segment elevation MI (NSTEMI), is still a leading cause of death worldwide. Metabolomics technology was used to explore differential metabolites (DMs) as potential biomarkers for early diagnosis of STEMI and NSTEMI. In the study, 2531 metabolites, including 1925 DMs, were discovered. In the selected 27 DMs, 14 were successfully verified in a new cohort, and the AUC values were all above 0.8. There were 10 in STEMI group, namely L-aspartic acid, L-acetylcarnitine, acetylglycine, decanoylcarnitine, hydroxyphenyllactic acid, ferulic acid, itaconic acid, lauroylcarnitine, myristoylcarnitine, and cis-4-hydroxy-D-proline, and 5 in NSTEMI group, namely L-aspartic acid, arachidonic acid, palmitoleic acid, D-aspartic acid, and palmitelaidic acid. These 14 DMs may be developed as biomarkers for the early diagnosis of MI with high sensitivity and specificity. These findings have particularly important clinical significance for NSTEMI patients because these patients have no typical ECG changes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersMetabolomicsMyocardial InfarctionHumansMaleMiddle AgedFemaleAgedST Elevation Myocardial InfarctionNon-ST Elevated Myocardial InfarctionMetabolome

Stichwörter der Autor:innen

NSTEMISTEMIacute coronary syndromebiomarkermetabolomics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Cardiac Surgery & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular Hospital, Tianjin University, Tianjin 300457, China.
  • Tianjin Key Laboratory of Molecular Regulation of Cardiovascular Diseases and Translational Medicine, Tianjin 300457, China.
  • Department of Cardiac Surgery & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences, Tianjin 300457, China.
  • Department of Cardiology & The Institute of Cardiovascular Diseases and the Critical Care Unit, TEDA International Cardiovascular Hospital, Tianjin University, Chinese Academy of Medical Sciences, Tianjin 300457, China.

ORCID-Profile: Guo-Wei He

Förderung

  • National Natural Science Foundation of China
  • Tianjin Municipal Science and Technology Commission
  • Chinese Academy of Medical Sciences
  • TEDA International Cardiovascular Hospital
  • Tianjin Key Medical Discipline (Specialty) Construction Project
  • Tianjin Municipal Heath Commission
  • Tianjin Municipal Science and Technology Bureau
  • Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences

Zitieren

APA

Zhou, J., Hou, H. T., Song, Y., Zhou, X. L., Chen, H. X., Zhang, L. L., Xue, H. M., Yang, Q., & He, G. W. (2024). Metabolomics Analysis Identifies Differential Metabolites as Biomarkers for Acute Myocardial Infarction. Biomolecules, 14(5), 532. https://doi.org/10.3390/biom14050532

Vancouver

Zhou J, Hou HT, Song Y, Zhou XL, Chen HX, Zhang LL, et al. Metabolomics Analysis Identifies Differential Metabolites as Biomarkers for Acute Myocardial Infarction. Biomolecules. 2024;14(5):532. doi:10.3390/biom14050532

BibTeX
@article{Zhou2024,
  author = {Zhou, Jie and Hou, Hai-Tao and Song, Yu and Zhou, Xiao-Lin and Chen, Huan-Xin and Zhang, Li-Li and Xue, Hong-Mei and Yang, Qin and He, Guo-Wei},
  title = {Metabolomics Analysis Identifies Differential Metabolites as Biomarkers for Acute Myocardial Infarction},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {5},
  pages = {532},
  doi = {10.3390/biom14050532}
}
Kostenlos starten →